Form 8-K - Current report:
SEC Accession No. 0001410578-19-001349
Filing Date
2019-09-20
Accepted
2019-09-20 16:36:43
Documents
16
Period of Report
2019-09-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv529829_8k.htm   iXBRL 8-K 39838
2 EXHIBIT 10.1 tv529829_ex10-1.htm EX-10.1 131593
3 EXHIBIT 10.2 tv529829_ex10-2.htm EX-10.2 140216
4 EXHIBIT 10.3 tv529829_ex10-3.htm EX-10.3 47108
8 GRAPHIC tv529829_ex10-2img01.jpg GRAPHIC 11841
  Complete submission text file 0001410578-19-001349.txt   611001

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA qure-20190916.xsd EX-101.SCH 3184
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20190916_lab.xml EX-101.LAB 33476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20190916_pre.xml EX-101.PRE 21957
12 EXTRACTED XBRL INSTANCE DOCUMENT tv529829_8k_htm.xml XML 3352
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 191105125
SIC: 2834 Pharmaceutical Preparations